Dec 12,2019

Express Scripts Includes Propeller Health in Its First Formulary for Digital Health Solutions

Express Scripts today announced its first formulary for digital and mobile health apps and devices, which will include Propeller Health’s digital health platform for asthma and COPD. According to Express Scripts, the Digital Health Formulary enables participating health plans and employers to increase patients’ access to emerging products and technologies simply and affordably. People who use a program on the Digital Health Formulary will receive support from Express Scripts specialist pharmacists to ensure appropriate use of the technology.

COLLABORATION PARTNERSHIP

#institution

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 12,2019

Express Scripts details programs, companies selected for its digital health formulary

About eight month after its unveiling, Express Scripts has now revealed the companies and programs it is including in the inaugural cohort of its digital health formulary — the first such resource from a pharmacy benefits manager designed to help clients review vetted digital health programs. These services, designated as either a preferred or alternative option, come from Livongo, Omada Health, LifeScan (powered by Welldoc), Propeller Health, Learn to Live and SilverCloud Health. Express Scripts, meanwhile, benefits by collecting compensation for the digital services provided to clients, and by providing an enticing offering that will satisfy both existing and new customers.

COLLABORATION PARTNERSHIP

#institution

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 16,2019

Voluntis collaborates with Salesforce to introduce full-service platform for digital therapeutics prescription and reimbursement

Voluntis today announced its collaboration with Salesforce, the global leader in CRM, to implement Voluntis Practice Solutions (VPS), its full-service platform supporting DTx prescription and reimbursement. Salesforce’s Health Cloud, Community Cloud, Sales Cloud and Einstein Analytics solutions will be deployed together to power VPS.

COLLABORATION PARTNERSHIP

#product & service

#pdt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Nov 13,2019

Blue Cross and Blue Shield of Minnesota Launches Omada’s Type 2 Diabetes Management Program

Deepening a collaboration that began in 2013, Omada Health and Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the availability of Omada’s Type 2 Diabetes Digital Care program as a covered benefit for the insurer’s commercial plans. Building on the two organizations’ success deploying digital diabetes prevention in the state, Omada’s type 2 diabetes program will be available for Minnesota employers to launch beginning January 2020. Blue Cross also announced a strategic investment in Omada Health through the insurer’s parent company.

COLLABORATION PARTNERSHIP

#insurance

#reimbursement

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 29,2019

Realizing the promise of prescription digital therapeutics

Corey McCann, M.D., is the president and CEO of Pear Therapeutics writes about the rise of prescription digital therapeutics and the upcoming trends in the market.

#pdt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jul 11,2019

Germany’s new law allows doctors to prescribe apps with health benefits

Germany has passed a law allowing doctors to prescribe digital apps with health benefits, which can be reimbursed by the country’s health insurance system. Germany is following the example of the US, which over the last few years has introduced a system where the FDA is able to approve apps that have trial evidence showing clinical benefits.

#reimbursement

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 19,2019

Deals, program launches headline digital health payer news during Q2 2019

Digital health-focused moves from payers throughout the last quarter ranged from partnership agreements and program launches to acquisitions and CMS coverage rulings. Several such headlines came from major players like Cigna, UnitedHealth Group, pharmacy benefit managers (PBMs) and various Blue Cross plans, and frequently involved digital health mainstays such as Livongo, Fitbit, Doctor on Demand and more.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jul 26,2019

New PBM programs offer road to validity, adoption for digital therapeutics

In May, pharmacy benefit manager Express Scripts announced it will be releasing a stand-alone digital health formulary next year, which it will use to highlight digital health tools of quality for its customers. A month later, CVS Health took a similar step with the rollout of Vendor Benefit Management, a service that will help CVS Caremark PBM clients roll out and manage third-party health products.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Apr 09,2019

Report: Roadblocks, successes of fledgling pharma-digital therapeutics partnerships will define industry’s future

Although still in its earliest chapters, the story of digital therapeutics is beginning to pick up steam. As more and more digital treatments come onto the market, the successes or failures of these partnerships and others will likely play a major role in defining the broader landscape of pharma-backed digital therapeutics, according to a new report from Rock Health and ZS Associates. Built from interviews with nearly 30 individuals representing pharma, digital therapeutics and health plans, the investigation outlines the industry’s current state and many of the roadblocks facing Pharma-digital therapeutics partnerships.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Jul 03,2018

BCBS Covers Hygieiea's Service

In late June, Blue Cross Blue Shield of Michigan made a deal with digital insulin therapy company Hygieia making its d-Nav Insulin Guidance Service available to members, following new data results. At the American Diabetes Association conference the insulin management company announced that in a study of the technology, patients in its trial group saw an average HbA1c reduction of 1.0 percent, versus 0.3 percent in the control group. In addition, patients also reported high satisfaction results and comfort with the d-Nav service, according to the company.

COLLABORATION PARTNERSHIP

#insurance

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Subscribe to REIMBURSEMENT